This is with reference to the intimation made by the Company vide its letter dated 15th December, 2022 bearing Ref No.-GHL/2022-23/EXCH/010. In this context, please find attached herewith a copy of presentation made thereat.
Any use of this material without specific permission of Global Health Pvt. Ltd. is strictly prohibited
This presentation, apart from historical information, contains some "forward-looking statements" including those describing the Company's strategies, strategic direction, objectives, future prospects, estimates etc. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by these statements. These factors include, but are not limited to general market conditions, macro-economic, movements in currency exchange and interest rates, the ability to attract and retain high quality human resource, competitive pressures, technological developments, governmental and regulatory trends, legislative developments, and other key factors beyond the control of the Company.
These forward looking statements are based on information currently available to us, and we assume no obligation to revise these statements as circumstances change. The Company may alter, modify or otherwise change in any manner the content of Presentation/Press Release, without obligation to notify any person of such revision or changes.
Over 2,467* operational beds expanding to 3,500+ by FY2025E
Network of 5 multi-speciality hospitals, 1 under construction hospital and 5 clinics across 8 cities
4.7 million sq. ft. of built up area** with additional land for expansion
Facilities for over 30 medical specialties
1,300+ doctors
69 operation theatres**,
523 ICU beds**
Over 25,000
surgeries annually
More than 2 million patients treated**
8,000+ full-time employees and retainer-based staff*
Accredited by
JCI and NABH
As of June 30, 2022
During fiscal 2022
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Global Health Ltd. published this content on 16 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2022 13:32:07 UTC.
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
GLOBAL HEALTH LIMITED 
